Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:27 AM
Ignite Modification Date:
2025-12-25 @ 2:27 AM
NCT ID:
NCT02384434
Eligibility Criteria:
Inclusion Criteria:
* Male or female patients ≥ 18 years of age
* Karnofsky performance status \> 70
* Histologic proof of squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, or larynx
* No prior radiotherapy to the head and neck region.
* No previous systemic chemotherapy or targeted therapy
* Must be aware of the neoplastic nature of his/her disease and willingly provide written, informed consent after being informed of the procedure to be followed, the nature of the therapy, alternatives, potential benefits, side-effects, risks and discomforts.
* Patients using standard therapies for cetuximab-induced acne-form rash will be included.
Exclusion Criteria:
* Evidence of distant metastasis on upright chest x-ray (CXR), computed tomography (CT) or other staging studies
* Any co-morbidity or condition of sufficient severity to limit full compliance with the protocol per assessment by the investigator
* Concurrent serious infection
* Continued use of Niacin
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02384434
Study Brief:
Protocol Section:
NCT02384434